Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the BARCODE 1 study on the early detection of prostate cancer using saliva samples to identify high-risk patients.

The Government has invested £16 million in the £42 million, United Kingdom-wide TRANSFORM trial, led by Prostate Cancer UK, which aims to identify new ways of detecting prostate cancer at an earlier stage, including in men without symptoms. The BARCODE 1 study tests are being included in the TRANSFORM trial, and the UK National Screening Committee will be assessing the evidence that emerges from this trial as it is published.